Riken Vitamin (4526.T) Earnings Analysis
Riken Vitamin (4526.T) next reports earnings on 2026-08-07. Trailing P/E 13.08.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4526.T next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 23.50B |
4526.T earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-12 | 87.72 JPY | n/a | n/a | n/a |
| 2025-11-13 | 51.87 JPY | n/a | n/a | n/a |
| 2025-08-08 | 61.16 JPY | n/a | n/a | n/a |
| 2025-02-14 | 84.95 JPY | n/a | n/a | n/a |
| 2024-08-09 | 78.07 JPY | n/a | n/a | n/a |
4526.T valuation and analyst view
| Trailing P/E | 13.08 |
|---|---|
| Trailing EPS | 242.47 JPY |
| Price / book | 1.08 |
| Dividend yield | 3.53% |
| Market cap | 92.38B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Riken Vitamin (4526.T)'s next earnings date?
Riken Vitamin is next scheduled to report on 2026-08-07 and revenue estimate of 23.50B.
Did 4526.T beat earnings last quarter?
Consensus estimate data was not available for 4526.T's 2026-02-12 report.
What is 4526.T's current P/E ratio and EPS?
4526.T trades at a trailing P/E of 13.08 on trailing EPS of 242.47019091598318 JPY.
What do analysts rate 4526.T?
4526.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.